Cytochrome P-450-derived eicosanoids participate in the renal functional effects of ET-1 in the anesthetized rat
Department of Pharmacology, New York Medical College, Valhalla, New York 10595 We evaluated the contribution of cytochrome P -450 (CYP450)-dependent arachidonic acid (AA) metabolites and prostanoids to the renal hemodynamic and tubular effects of endothelin-1 (ET-1) in anesthetized rats. Either ET-1...
Gespeichert in:
Veröffentlicht in: | American journal of physiology. Regulatory, integrative and comparative physiology integrative and comparative physiology, 1998-01, Vol.274 (1), p.52-R61 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Department of Pharmacology, New York Medical College, Valhalla, New
York 10595
We evaluated the contribution of cytochrome
P -450 (CYP450)-dependent arachidonic
acid (AA) metabolites and prostanoids to the renal hemodynamic and
tubular effects of endothelin-1 (ET-1) in anesthetized rats. Either
ET-1 (0.3, 1.0, and 3 pmol · kg 1 · min 1 )
or vehicle was infused intravenously during two to three 30-min clearance experimental periods. Only high-dose ET-1 increased mean
arterial pressure: control, 75 ± 3 mmHg vs. experimental, 84 ± 4 mmHg. A dose-dependent diuretic-natriuretic response to ET-1
occurred despite progressive declines in glomerular filtration rate
(GFR) and renal blood flow. In the face of a 36% reduction in GFR in
response to the highest dose of ET-1, urinary sodium excretion
(U Na V) increased threefold from
0.57 ± 0.11 to 1.6 ± 0.10 µmol · 100 g 1 · min 1 .
Indomethacin (5 mg/kg) decreased basal GFR from 1.2 ± 0.3 ml · 100 g 1 · min 1
to 0.8 ± 0.1 ml · 100 g 1 · min 1
and potentiated the GFR lowering action of ET-1 associated with reductions in U Na V and urine
volume. Cobalt chloride (CoCl 2 )
and dibromododec-11-enoic acid (DBDD), which diminish CYP450-dependent AA metabolism through different mechanisms, were used to identify CYP450 products mediating the renal functional actions of ET-1. DBDD
(12.5 µg/min) reduced urinary excretion of 20-hydroxyeicosatetraenoic acid from 3.4 ± 0.9 (control) to 1.1 ± 0.6 ng/h and abolished the
negative effects of ET-1 on GFR while decreasing the
diuretic-natriuretic action of ET-1. Similar effects were produced by
CoCl 2 . Clotrimazole, an inhibitor
of epoxygenase activity, was without effect on ET-1-induced renal
functional changes. Thus the capacity of ET-1 to enhance prostaglandin
production was primarily expressed in terms of positive effects on
renal hemodynamics. In contrast, CYP450 products promoted sodium
excretion despite negative effects on renal hemodynamics.
endothelin-1; renal hemodynamics; dibromododec-11-enoic acid; indomethacin; clotrimazole; cobalt chloride |
---|---|
ISSN: | 0363-6119 0002-9513 1522-1490 |
DOI: | 10.1152/ajpregu.1998.274.1.R52 |